Roland Kolbeck

Chief Tech/Sci/R&D Officer at ACLARIS THERAPEUTICS, INC.

Net worth: 124 748 $ as of 30/07/2026

62 year

Health Technology

Consumer Services

Profile

Dr. Roland Kolbeck is a Chief Scientific Officer at Aclaris Therapeutics, Inc. Dr. Kolbeck was previously employed as a Chief Scientific Officer by Spirovant Sciences, Inc. He received his graduate degree from the University of Regensburg.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ACLARIS THERAPEUTICS, INC. 0.02%	31/07/2026	23,990 ( 0.02% )	124 748 $	30/07/2026

Roland Kolbeck active positions

Companies	Position	Start
ACLARIS THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	27/07/2025

All active positions of Roland Kolbeck

Former positions of Roland Kolbeck

Companies	Position	End
Spirovant Sciences, Inc. Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy	Chief Tech/Sci/R&D Officer	-

See the detail of Roland Kolbeck's experience

Training of Roland Kolbeck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roland Kolbeck's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases	Health Technology
University of Regensburg University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spirovant Sciences, Inc. Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy	Health Technology